Search

everythinglearnresearchcommunity

for

Search:↓

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Glycated hemoglobin is not as effective as the oral glucose tolerance test for diagnosing blood sugar problems in women with PCOS in Southern Iraq.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.